Whole exome sequencing (WES) test

  • WES is Whole Exome Sequencing (Whole Exome Sequencing), i.e. exomes (coding fragments) of all, i.e. more than 23 500 human genes.

  • In the human genome (all DNA) there are more than 180,000 exons, which accounts for less than 2% of the total sequence, but within the exome there are about 80-90% of the mutations responsible for the diseases.

  • The test is performed using technology NGS, or Next Generation Sequencing. The WES study has huge advantage over standard genetic tests, in which only single mutations within a gene are analyzed.

  • m

Why is our approach innovative, compared to other laboratories?


  1. The waiting time for the result is only 4 weeks from the delivery of the material to the labotarium

  2. The patient has the option to purchase subscription (does not burden his budget in this way one time)

  3. As part of the subscription, the patient can select additionalany analysis (if a particular disease entity we will create such a panel of tests up to 7 days).

  4. The analysis of sequencing data performed in our laboratory includes all known mutations, also referred to as variants or so-called SNPs. SNPs (single-nucleotide polymorphisms)associated with a particular disease entity.

  5. The result of bioinformatics analysis determines the clinical status of the detected variants, predictive analysis, and visualization of the obtained results.

  6. The result of the test is consulted with specialist in the relevant medical field.

  7. Each result is updated with the latest scientific data every 6 months.

Find the genetic test (type in the name of the disease unit or gene)

Sample WES test result: